학술논문
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).
Document Type
Journal Article
Author
Source
Subject
*SQUAMOUS cell carcinoma
*OLDER patients
*THERAPEUTIC use of antineoplastic agents
*RESEARCH
*CLINICAL trials
*RESEARCH methodology
*ANTINEOPLASTIC agents
*EVALUATION research
*MEDICAL cooperation
*TREATMENT effectiveness
*COMPARATIVE studies
*SURVIVAL analysis (Biometry)
*ESOPHAGEAL tumors
*ANTIGENS
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1471-2407
Abstract